Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

68 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Molecular biology of the CRH receptors-- in the mood.
Dautzenberg FM, Kilpatrick GJ, Hauger RL, Moreau J. Dautzenberg FM, et al. Peptides. 2001 May;22(5):753-60. doi: 10.1016/s0196-9781(01)00388-6. Peptides. 2001. PMID: 11337088 Review.
Establishment of robust functional assays for the characterization of neuropeptide Y (NPY) receptors: identification of 3-(5-benzoyl-thiazol-2-ylamino)-benzonitrile as selective NPY type 5 receptor antagonist.
Dautzenberg FM, Higelin J, Pflieger P, Neidhart W, Guba W. Dautzenberg FM, et al. Neuropharmacology. 2005 Jun;48(7):1043-55. doi: 10.1016/j.neuropharm.2005.01.020. Neuropharmacology. 2005. PMID: 15857631
Irreversible binding kinetics of neuropeptide Y ligands to Y2 but not to Y1 and Y5 receptors.
Dautzenberg FM, Neysari S. Dautzenberg FM, et al. Pharmacology. 2005 Dec;75(1):21-9. doi: 10.1159/000085897. Epub 2005 May 20. Pharmacology. 2005. PMID: 15908753
GRK3 regulation during CRF- and urocortin-induced CRF1 receptor desensitization.
Dautzenberg FM, Wille S, Braun S, Hauger RL. Dautzenberg FM, et al. Biochem Biophys Res Commun. 2002 Nov 1;298(3):303-8. doi: 10.1016/s0006-291x(02)02463-4. Biochem Biophys Res Commun. 2002. PMID: 12413940
Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.
Hauger RL, Risbrough V, Brauns O, Dautzenberg FM. Hauger RL, et al. Among authors: dautzenberg fm. CNS Neurol Disord Drug Targets. 2006 Aug;5(4):453-79. doi: 10.2174/187152706777950684. CNS Neurol Disord Drug Targets. 2006. PMID: 16918397 Free PMC article. Review.
Molecular cloning and functional expression of the mouse CRF2(a) receptor splice variant.
Dautzenberg FM, Higelin J, Wille S, Brauns O. Dautzenberg FM, et al. Regul Pept. 2004 Sep 15;121(1-3):89-97. doi: 10.1016/j.regpep.2004.04.009. Regul Pept. 2004. PMID: 15256278
Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.
Dautzenberg FM, Wille S. Dautzenberg FM, et al. Regul Pept. 2004 May 15;118(3):165-73. doi: 10.1016/j.regpep.2003.12.012. Regul Pept. 2004. PMID: 15003833
International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands.
Hauger RL, Grigoriadis DE, Dallman MF, Plotsky PM, Vale WW, Dautzenberg FM. Hauger RL, et al. Among authors: dautzenberg fm. Pharmacol Rev. 2003 Mar;55(1):21-6. doi: 10.1124/pr.55.1.3. Pharmacol Rev. 2003. PMID: 12615952 Review.
Secondary structure of antisauvagine analogues is important for CRF receptor antagonism: development of antagonists with increased potency and receptor selectivity.
Brauns O, Brauns S, Jenke M, Zimmermann B, Dautzenberg FM. Brauns O, et al. Among authors: dautzenberg fm. Peptides. 2002 Oct;23(10):1817-27. doi: 10.1016/s0196-9781(02)00139-0. Peptides. 2002. PMID: 12383870
The CRF peptide family and their receptors: yet more partners discovered.
Dautzenberg FM, Hauger RL. Dautzenberg FM, et al. Trends Pharmacol Sci. 2002 Feb;23(2):71-7. doi: 10.1016/s0165-6147(02)01946-6. Trends Pharmacol Sci. 2002. PMID: 11830263 Review.
68 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback